Trade EMBC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Embecta Corp. (EMBC) is trading at US$5.91, down 0.67% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$296.33M. Over the past 52 weeks, EMBC has traded between US$2.77 and US$14.91. On Syfe you can trade EMBC with $0 commission and add it to your watchlist.
| Previous close | US$5.95 |
|---|---|
| Market cap | US$296.33M |
| P/E ratio | 3.35 |
| 52-week range | US$2.77 – US$14.91 |
| Dividend yield | 5.31% |
| Volume | 994.13K |
| Exchange | US |
Embecta Corp.
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Year: 2022
BofA Securities Adjusts Price Target on Embecta to $3 From $11
May 18, 12:16 PM · MT Newswires
Embecta Closes Acquisition of Owen Mumford
May 15, 1:30 PM · MT Newswires
BTIG Downgrades Embecta to Neutral From Buy
May 6, 12:00 PM · MT Newswires
Embecta Corp. (EMBC) stock is trading at US$5.91, -0.67% from the previous close of US$5.95.
The market cap for Embecta Corp. (EMBC) stock is approximately US$296.33M.
The price-to-earnings ratio for Embecta Corp. (EMBC) is 3.35, based on the latest reported earnings.
The 52-week high for Embecta Corp. (EMBC) stock is US$14.91.
The 52-week low for Embecta Corp. (EMBC) stock is US$2.77.
Yes, Embecta Corp. (EMBC) pays a dividend. The trailing 12-month dividend yield is 5.31%.
Stay on top of EMBC
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore